Astrazeneca Plc (AZN)
Prescription drugs are a dime a dozen these days, but AstraZeneca goes after the heavy hitters: cancer, cholesterol, asthma, and psychotic problems.
| Yearly Income Statement | 2011 Annual |
|---|---|
|
All the money that a company makes from selling their products or services. Kind of like your salary. 
Total Revenue
|
$33.59b |
|
What companies get to keep after paying for the costs of selling their product. So if you sell lemonade for $1 and it costs you 50 cents to make, your gross profit is 50 cents.
Gross Profit
|
$27.49b |
|
The money they generate solely from their core business. So the money you make at a garage sale doesn't count, but your salary does.
Operating Income
|
$12.96b |
|
The bottom line -- what they get to keep after paying all of their expenses. It's what's left of your salary after paying for your needs that you can put towards your wants.
Net Income
|
$9.98b |
| Balance Sheet | |
|
Everything a company has that will be turned into cash within a year. This includes things like inventory or money they are owed.
Total Current Assets
|
$23.51b |
|
All the stuff the company needs to pay off within a year. It's basically the opposite of total current assets.
Total Current Liabilities
|
$15.75b |
|
Take everything the company owns and subtract what they owe -- it's what belongs to the shareholders. Think of it as your net worth.
Total Equity
|
$23.47b |
| Cash Flow | |
|
The bottom line -- what they get to keep after paying all of their expenses. It's what's left of your salary after paying for your needs that you can put towards your wants.
Net Income/Starting Line
|
$9.98b |
|
The cash that companies make from their core business of selling products or services. If you sell lemonade, it's the cash you make from selling it.
Cash from Operating
|
$7.82b |
|
This is the cash that companies make from their investments. If you invest in a second lemonade stand, this is where it would go.
Cash from Investing
|
$-2.02b |
|
Changes in debt, loans and dividends. If a neighbor owes you for a glass of lemonade you gave him for free or if you owe someone else, it would show up here.
Cash from Financing
|
$-9.32b |
|
Has the amount of cash gone up or down? This number shows how much more (or less) they made over time. Are things getting better or worse?
Net Change in Cash
|
$-3.55b |
Events
-
May232012AstraZeneca PLC Presents at Biomarkers World Europe, May-22-2012 through May-25-2012
-
May262012Arcturus Ventures Inc. expected to report Q3 2012 results on May 26, 2012. This event was calculated by Capital IQ (Created on March 8, 2012).
-
October252012AstraZeneca PLC to Report Q3, 2012 Results on Oct 25, 2012
-
October282012Arcturus Ventures Inc. expected to report Fiscal Year 2012 results on October 28, 2012. This event was calculated by Capital IQ (Created on November 13, 2011).
-
January312013AstraZeneca PLC expected to report Fiscal Year 2012 results on January 31, 2013. This event was calculated by Capital IQ (Created on February 3, 2012).
Members who own this company also own
Current price per share
Today's gain: $-0.42 (-1.00%)
